Eli Lilly Helps Organize Education Program On Prevention Of Common Respiratory Infectious Disease
This article was originally published in PharmAsia News
Eli Lilly and the committee on national care series activities recently kicked off an education program called "family medicine kit" that targets common respiratory infectious disease prevention in Beijing. The program will include educational activities in areas with a high prevalence of infectious disease by distributing free handbooks, posters and flyers and by starting a special column in the media. To be rolled out in three phases, the family medicine kit will be progressively launched in 40 major cities nationwide, directly benefiting more than 8 million people. Targeted mainly at the female population, the program will publicize knowledge of family health management, family drug safety, family nursing and first aid, common disease prevention and treatment, and respiratory infectious disease prevention. (Click here for more - Chinese Language)
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.